Table 4.

Influence of the synthetic compounds on ECG amplitude P wave. Normal group referring to anesthesia group without any treatments, pre-dose group referring to BaCl₂-treated group and post-dose group referring to compounds-treated group.

Group	P Wave (mV)
	Normal	Pre-Dose	Post-Dose
NS	0.096 ± 0.026	0.060 ± 0.012 **	0.150 ± 0.041
DMSO	0.105 ± 0.012	0.071 ± 0.003 **	0.100 ± 0.020 *
Ve r(2 mg/kg)	0.116 ± 0.011	0.076 ± 0.027 **	0.228 ± 0.027 ▲
Scutellarein (8 mg/kg)	0.116 ± 0.017	0.073 ± 0.013 ***	0.188 ± 0.040
3 (8 mg/kg)	0.128 ± 0.015	0.053 ± 0.021 ***	0.215 ± 0.044 #▲▲
7a (8 mg/kg)	0.121 ± 0.017	0.063 ± 0.015 ***	0.171 ± 0.052 *
7b (8 mg/kg)	0.136 ± 0.013	0.098 ± 0.032 **	0.200 ± 0.042 *
7c (8 mg/kg)	0.091 ± 0.033	0.070 ± 0.015	0.145 ± 0.038
7d (8 mg/kg)	0.146 ± 0.019	0.088 ± 0.033 ***	0.183 ± 0.051 ##▲▲▲
7e (8 mg/kg)	0.118 ± 0.010	0.065 ± 0.009 ***	0.156 ± 0.033
7f (8 mg/kg)	0.178 ± 0.024	0.108 ± 0.006 ***	0.133 ± 0.020 **###▲▲▲
7g (8 mg/kg)	0.163 ± 0.037	0.086 ± 0.011 ***	0.121 ± 0.022 ###▲▲▲
8a (8 mg/kg)	0.110 ± 0.015	0.083 ± 0.014 *	0.170 ± 0.053
10a (8 mg/kg)	0.128 ± 0.017	0.096 ± 0.015 **	0.188 ± 0.042 #▲
10b (8 mg/kg)	0.115 ± 0.026	0.071 ± 0.022 **	0.153 ± 0.054 ▲
10c (8 mg/kg)	0.110 ± 0.027	0.073 ± 0.024 ***	0.186 ± 0.045
10d (8 mg/kg)	0.111 ± 0.013	0.048 ± 0.010 ***	0.170 ± 0.061
10e (8 mg/kg)	0.130 ± 0.025	0.066 ± 0.024 ***	0.135 ± 0.016
10f (8 mg/kg)	0.116 ± 0.025	0.045 ± 0.013 ***	0.138 ± 0.059 #▲▲
11f (8 mg/kg)	0.115 ± 0.012	0.083 ± 0.017 *	0.156 ± 0.038 ##▲▲▲
12a (8 mg/kg)	0.118 ± 0.016	0.061 ± 0.006 ***	0.136 ± 0.051 **
13a (8 mg/kg)	0.090 ± 0.012	0.025 ± 0.007 ***	0.123 ± 0.015
13b (8 mg/kg)	0.118 ± 0.012	0.071 ± 0.010 ***	0.161 ± 0.017
14a (8 mg/kg)	0.098 ± 0.017	0.060 ± 0.014 **	0.111 ± 0.008
14b (8 mg/kg)	0.111 ± 0.006	0.083 ± 0.012 *	0.128 ± 0.008

Compared with Normal: * p < 0.05 ** p < 0.01 *** p < 0.001; Compared with NS: # p < 0.05 ## p < 0.01 ### p < 0.001; Compared with DMSO: ▲ p < 0.05 ▲▲ p < 0.01 ▲▲▲ p < 0.001; Data represent mean ± SD. n = 6.